Clinical Trial Update: Trial of Suvorexant for Sleep in Children With Autism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating suvorexant as a treatment for sleep problems in children with autism and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Belsomra (suvorexant)

Snippet

Sponsor: Stanford University | Conditions: Autism, Autism Spectrum Disorder | Phase 2 | Status: RECRUITING